Bright Minds Biosciences Inc $DRUG

Health Care

$52.69
+2.25 (+4.46%)
As of Oct 22, 2026, 9:34 PM EDT · cached
Price history
Loading chart…

Bright Minds Biosciences Inc (DRUG) is trading up at $52.69 (+4.46%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Bright Minds Biosciences Inc net income history (FY2020–FY2024)

Net income
CA$0−CA$7.48M−CA$15.0MFY2020 net income: −CA$480.4K'20FY2021 net income: −CA$8.65M'21FY2022 net income: −CA$15.0M'22FY2023 net income: −CA$7.37M'23FY2024 net income: −CA$2.80M'24
Bright Minds Biosciences Inc annual financial statements
FY2020Sep 2020FY2021Sep 2021FY2022Sep 2022FY2023Sep 2023FY2024Sep 2024
Income statement
Net income−CA$480.4K−CA$8.65M−CA$15.0M−CA$7.37M−CA$2.80M
EPS (diluted)−CA$0.65−CA$4.82−CA$6.06−CA$1.98−CA$0.65
Balance sheet
Cash and equivalentsCA$799.9KCA$19.8MCA$11.6MCA$6.75MCA$5.72M
Total assetsCA$880.2KCA$20.0MCA$12.1MCA$6.88MCA$6.10M
Total liabilitiesCA$150.9KCA$638.6KCA$1.54MCA$280.9KCA$568.3K
Shareholders' equityCA$729.3KCA$19.4MCA$10.5MCA$6.60MCA$5.54M
Cash flow
Operating cash flow−CA$288.4K−CA$7.32M−CA$13.6M−CA$7.02M−CA$1.85M

From Bright Minds Biosciences Inc's 20-F filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. Amounts are in Canadian Dollar (CAD), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →

About Bright Minds Biosciences Inc

Headquarters
Chicago, Illinois From SEC filings, Oct 2026

Recent News (2)

More Health Care stocks

Browse all companies →